Development of recommendations for dosing of commonly prescribed medications in critically ill obese children-Reference-Cited by-同舟云学术

Development of recommendations for dosing of commonly prescribed medications in critically ill obese children

Published:2015-04-01 Issue:7 Volume:72 Page:542-556
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Ross Emma L.¹,Heizer Justin²,Mixon Mark A.²,Jorgensen Jennifer³,Valdez Connie A.⁴,Czaja Angela S.⁵,Reiter Pamela D.⁶

Affiliation:

1. American Family Children’s Hospital, UW Hospital and Clinics, Madison, WI; at the time of writing she was Pharmacy Practice Resident, Department of Pharmacy, Children’s Hospital Colorado, Aurora

2. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado (UC), Aurora

3. General Medicine, Department of Pharmacy, Children’s Hospital Colorado

4. Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC

5. Division of Critical Care, Department of Pediatrics, School of Medicine, and Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC

6. Pediatric Intensive Unit, Department of Pharmacy, Children’s Hospital Colorado, and Clinical Associate Professor of Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/72/7/542/28319314/ajhp0542.pdf

Reference22 articles.

1. Changes in the state-specfic childhood obesity and overweight prevalence in the United States from 2003 to 2007;Singh;Arch Pediatr Adolesc Med,2010

2. Dosing dilemmas in obese children;Mulla;Arch Dis Child Educ Pract Ed,2010

3. Pharmacokinetics and drug dosing in obese children;Kendrick;J Pediatr Pharmacol Ther,2010

4. Food and Drug Administration. Drug research and children. www.fda.gov/Drugs/Resourcesforyou/consumers/UCM143565.htm (accessed 2014 Mar 1).

5. What is the best size descriptor to use for pharmacokinetic studies in the obese?;Green;Br J Clin Pharmacol,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Quality Initiative to Improve Appropriate Medication Dosing in Pediatric Patients with Obesity;Pediatric Quality & Safety;2024-05

2. The Impact of Paediatric Obesity on Drug Pharmacokinetics: A Virtual Clinical Trials Case Study with Amlodipine;Pharmaceutics;2024-04-02

3. Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice;Hospital Pharmacy;2024-02-07

4. Safe Prescribing and Monitoring in Pediatrics;Principles and Practice of Pharmacovigilance and Drug Safety;2024

5. The health care provider's needs in the pediatric drug development process;Essentials of Translational Pediatric Drug Development;2024